vs
Clear Secure, Inc.（YOU）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Clear Secure, Inc.的季度营收约是再鼎医药的1.9倍（$240.8M vs $127.1M），再鼎医药同比增速更快（17.1% vs 16.7%），Clear Secure, Inc.自由现金流更多（$187.4M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 16.0%）
Clear Secure, Inc.是美国一家科技企业，主营生物识别旅行证件核验系统，其服务已覆盖部分大型机场与体育场馆。公司成立于2003年，2009年申请破产后停运，2012年重启运营，最终于2021年成功上市。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
YOU vs ZLAB — 直观对比
营收规模更大
YOU
是对方的1.9倍
$127.1M
营收增速更快
ZLAB
高出0.4%
16.7%
自由现金流更多
YOU
多$214.1M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
16.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.8M | $127.1M |
| 净利润 | $30.8M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 22.4% | -54.6% |
| 净利率 | 12.8% | — |
| 营收同比 | 16.7% | 17.1% |
| 净利润同比 | -70.2% | — |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收YOUZLAB
| Q4 25 | $240.8M | $127.1M | ||
| Q3 25 | $229.2M | $115.4M | ||
| Q2 25 | $219.5M | $109.1M | ||
| Q1 25 | $211.4M | $105.7M | ||
| Q4 24 | $206.3M | $108.5M | ||
| Q3 24 | $198.4M | $101.8M | ||
| Q2 24 | $186.7M | $100.1M | ||
| Q1 24 | $179.0M | $87.1M |
净利润YOUZLAB
| Q4 25 | $30.8M | — | ||
| Q3 25 | $28.3M | $-36.0M | ||
| Q2 25 | $24.7M | $-40.7M | ||
| Q1 25 | $25.4M | $-48.4M | ||
| Q4 24 | $103.3M | — | ||
| Q3 24 | $23.5M | $-41.7M | ||
| Q2 24 | $24.1M | $-80.3M | ||
| Q1 24 | $18.8M | $-53.5M |
毛利率YOUZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率YOUZLAB
| Q4 25 | 22.4% | -54.6% | ||
| Q3 25 | 23.0% | -42.3% | ||
| Q2 25 | 19.4% | -50.3% | ||
| Q1 25 | 17.7% | -53.3% | ||
| Q4 24 | 16.5% | -62.6% | ||
| Q3 24 | 17.7% | -66.6% | ||
| Q2 24 | 16.2% | -76.0% | ||
| Q1 24 | 13.2% | -80.7% |
净利率YOUZLAB
| Q4 25 | 12.8% | — | ||
| Q3 25 | 12.3% | -31.2% | ||
| Q2 25 | 11.3% | -37.3% | ||
| Q1 25 | 12.0% | -45.8% | ||
| Q4 24 | 50.1% | — | ||
| Q3 24 | 11.8% | -40.9% | ||
| Q2 24 | 12.9% | -80.2% | ||
| Q1 24 | 10.5% | -61.4% |
每股收益（稀释后）YOUZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $85.7M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $177.7M | $715.5M |
| 总资产 | $1.3B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资YOUZLAB
| Q4 25 | $85.7M | $689.6M | ||
| Q3 25 | $75.8M | $717.2M | ||
| Q2 25 | $89.3M | $732.2M | ||
| Q1 25 | $87.6M | $757.3M | ||
| Q4 24 | $66.9M | $779.7M | ||
| Q3 24 | $32.9M | $616.1M | ||
| Q2 24 | $39.1M | $630.0M | ||
| Q1 24 | $64.1M | $650.8M |
股东权益YOUZLAB
| Q4 25 | $177.7M | $715.5M | ||
| Q3 25 | $148.6M | $759.9M | ||
| Q2 25 | $121.3M | $791.7M | ||
| Q1 25 | $116.7M | $810.8M | ||
| Q4 24 | $198.4M | $840.9M | ||
| Q3 24 | $129.0M | $667.7M | ||
| Q2 24 | $153.5M | $704.2M | ||
| Q1 24 | $165.9M | $762.2M |
总资产YOUZLAB
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $858.6M | $985.3M | ||
| Q2 24 | $982.4M | $987.4M | ||
| Q1 24 | $1.0B | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.4M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $187.4M | $-26.7M |
| 自由现金流率自由现金流/营收 | 77.8% | -21.0% |
| 资本支出强度资本支出/营收 | 4.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 6.45× | — |
| 过去12个月自由现金流最近4个季度 | $343.1M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流YOUZLAB
| Q4 25 | $198.4M | $-26.0M | ||
| Q3 25 | $-47.3M | $-32.0M | ||
| Q2 25 | $123.0M | $-31.0M | ||
| Q1 25 | $98.3M | $-61.7M | ||
| Q4 24 | $136.6M | $-55.8M | ||
| Q3 24 | $-35.9M | $-26.8M | ||
| Q2 24 | $114.6M | $-42.2M | ||
| Q1 24 | $80.3M | $-90.1M |
自由现金流YOUZLAB
| Q4 25 | $187.4M | $-26.7M | ||
| Q3 25 | $-53.5M | $-35.0M | ||
| Q2 25 | $117.9M | $-33.9M | ||
| Q1 25 | $91.3M | $-63.2M | ||
| Q4 24 | $133.9M | $-58.4M | ||
| Q3 24 | $-37.9M | $-28.2M | ||
| Q2 24 | $110.1M | $-42.9M | ||
| Q1 24 | $77.6M | $-91.1M |
自由现金流率YOUZLAB
| Q4 25 | 77.8% | -21.0% | ||
| Q3 25 | -23.3% | -30.4% | ||
| Q2 25 | 53.7% | -31.1% | ||
| Q1 25 | 43.2% | -59.9% | ||
| Q4 24 | 64.9% | -53.8% | ||
| Q3 24 | -19.1% | -27.7% | ||
| Q2 24 | 59.0% | -42.9% | ||
| Q1 24 | 43.3% | -104.5% |
资本支出强度YOUZLAB
| Q4 25 | 4.6% | 0.5% | ||
| Q3 25 | 2.7% | 2.6% | ||
| Q2 25 | 2.3% | 2.6% | ||
| Q1 25 | 3.4% | 1.5% | ||
| Q4 24 | 1.3% | 2.4% | ||
| Q3 24 | 1.0% | 1.3% | ||
| Q2 24 | 2.4% | 0.7% | ||
| Q1 24 | 1.6% | 1.1% |
现金转化率YOUZLAB
| Q4 25 | 6.45× | — | ||
| Q3 25 | -1.67× | — | ||
| Q2 25 | 4.97× | — | ||
| Q1 25 | 3.87× | — | ||
| Q4 24 | 1.32× | — | ||
| Q3 24 | -1.53× | — | ||
| Q2 24 | 4.75× | — | ||
| Q1 24 | 4.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
YOU
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
